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Abstract Chromanols, which were recently shown to inhibit 
cAMP-mediated CI secretion in colon crypts via a blockade of 
a cAMP-activated K + conductance, were analyzed for their 
effects on distinct cloned K + channels expressed in Xenopus 
oocytes. The lead chromanol 293B specifically inhibited I~K 
channels with an ICs0 of 7 pmol/1 without affecting the delayed 
rectifier Kvl.1 or the inward rectifier Kir2.1. Moreover, several 
other chromanols displayed the same rank order of potency for 
Isx inhibition as demonstrated in colon crypts. Finally, we tested 
the effects of the previously described I~K blocker azimilide on 
cAMP mediated CI secretion in rat colon crypts. Similar to 
293B azimilide inhibited the forskolin induced CI- secretion. 
These data suggest that Isx protein induced K + conductances are 
the targets for the chromanol 293B and its analogues, and 
azimilide. 
Key words'." K + channel;  cAMP;  I~K; Chromanol ;  
C1- secretion 
I. Introduction 
Expression of the I~K protein in Xenopus oocytes induces 
slowly activating, voltage-dependent potassium IsK channels 
of an unknown subunit composit ion [1]. The gene encoding 
the I~K protein was shown to be expressed in uterus [2], heart 
[3] and a number  of epithelial cell types [1]. In cardiac ven- 
tricular myocytes, I~K channels contr ibute to the repolarizing 
currents during action potentials and may be targets for novel 
class III ant iarrhythmics [4]. The physiological role of I~K 
channels in epithelial cells is unclear. The activity of I~K chan- 
nels is regulated by a number  of second messengers including 
diacylglycerol, Ca 2+, nitric oxide, peroxides and cAMP [5]. 
Activation of K + channels by Ca 2+ and cAMP has been 
shown to provide the electrical driving force for C1- secretion 
in tracheal and colon epithelial cells [6-10]. Recently, Lohr- 
mann et al. [11] demonstrated that the inhibit ion of cAMP- 
activated K + channels by several chromanol  derivatives com- 
pletely abolishes C1 secretion in colon crypts. In whole-cell 
patch clamp experiments the inhibitory effects of these chro- 
manols were confirmed on the basolateral, cAMP-act ivated 
K + conductance in rat colon crypts [9,12]. The aim of this 
study was therefore to identify the molecular targets for these 
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chromanols and to test the putative involvement of I~K chan- 
nels in C1- secretion of colon epithelial cells. 
2. Materials and methods 
2.1. Electrophysiological experiments in Xenopus oocytes 
Handling and injection of Xenopus oocytes and synthesis of cRNA 
has been described previously in detail [13]. The two-microelectrode 
voltage clamp configuration was used to record currents from Xeno- 
pus laevis oocytes. In several sets of experiments oocytes were individ- 
ually injected with cRNA encoding each of the K + channels rat I~K 
[1], rat Kvl.l [14] or rat Kir2.1 [15]. Recordings were performed at 
22°C using a Geneclamp amplifier (Axon Instruments, Foster City, 
CA, USA) and MacLab D/A converter and software for data acquisi- 
tion and analysis (ADInstruments, Castle Hill, Australia). Outward 
currents through LK or Kvl.l channels were evoked with 15 s or 0.5 s 
depolarizing pulses to -10 mV from a holding potential of -80 mV, 
and filtered at 10 Hz and 1 kHz, respectively. K ~ inward currents 
through inwardly rectifying Kir2.1 channels were evoked by hyperpo- 
larizing the cells for 0.5 s to -120 mV from a holding potential of 
-40  mV (filtered at 1 kHz). The amplitudes of the recorded currents 
were measured at the end of the test voltage steps. The control solu- 
tion contained (mM): NaC1 96, KCI 2, CaCI2 1.8, MgCI2 1, HEPES 5 
(titrated with NaOH to pH 7.5 for the control solution). The micro- 
electrodes were filled with 3 M KCI solution and had resistances of 
0.5-0.9 M~. All chromanols used are listed in Table 1. Azimilide was 
a generous gift of Procter and Gamble Pharm. (Norwich, USA). For- 
skolin, IBMX and remaining reagents were purchased from Sigma (St. 
Louis, MO, USA). Data are presented as means with standard errors 
(S.E.M.), where n represents he number of experiments performed. A
paired Student's t-test was used to test for statistical significance, 
which was obtained for P < 0.05. 
2.2. Rat distal colon, Ussing chamber experiments 
Rats of either sex (body weight 100 200 g) were used. The animals 
were killed by decapitation. Ussing chamber experiments were per- 
formed as described recently [16]. The chambers were modified for rat 
tissue. The solutions on the two sides of the epithelia were circulated 
by a bubble lift system. The reservoirs were bubbled with carbogen 
(5% CO2 and 95% 02) and kept at 37°C by water jackets. The total 
volume on each side was approximately 15 ml. The solutions used on 
the two sides had the following composition (in mmol/1): NaC1 120, 
NaHCO3 25, K2PHO4 1.6, KH2PO4 0.4, Ca-gluconate 1.3, MgCI2 1, 
D-glucose 5. To this solution indomethacin (1 ~tmol/1) was added to 
inhibit endogenous prostaglandin formation. The measurements were 
performed in 'open circuit mode'. Transepithelial voltage (Vtc) was 
referenced to the serosal side. Transepithelial resistance (Rt,,) was 
obtained by applying calibrated short current pulses (I) every 6 s. 
The voltage deflection (AVt~0 caused by these current pulses with 
the mucosa-submucosa preparation present was corrected by that ob- 
tained for the empty chamber (AVte'). According to Ohm's law: 
Rt~,=(AVt~,--AVte')/I, the equivalent short circuit current (Is~) was 
determined from Vt~. and Rte:I~ = VtJRt~.. The usual protocol con- 
sisted of an equilibration period, usually 2-10 min. Then amiloride (10 
lamol/1) was added to the mucosal perfusate. This abolished the lumen 
negative voltage caused by electrogenic Na + reabsorption. Thereafter 
CI- secretion was stimulated by adding forskolin (10 ~mol/1) to the 
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Table 1: A list of the chromanols used, their IC5o value for IsK, and their chemical names. (n = number of experiments) 
Code Structure 
293B Racemate 
434B 
407B 
374B 
Racemate 
~.N.,SOJ 
N C ~ H  
-~N/SOJ  
N C ~ O H  
~N/SOJ  
i N C ~ O H  
~.N..SO~ - 
N c ~ O H  
ICso Ipmol/ll, chemical name Code Structure 
6.89 + 0.38, (n = 8) 439B 
Racemate 
tra ns-6-Cyano-4-(N-ethylsulphonyl- 
N-methylamino)-3-hyd roxy-2,2- 
dimethyl-chromane 
5.05 + 0.21, (n = 4) 
(+)-(3S,4R)-6-Cya no-4-(N- 
ethylsulphonyI-N-methylamino)-3- 
hydroxy-2,2-dimethyl-chromane 
30.7 + 1.24, (n = 4) 
(-)-(3R,4S)-6-Cya no-4-(N- 
ethylsulphonyI-N-methylamino)-3- 
hydroxy-2,2-dimethyl-chroma ne 
19.2 + 1.20, (n = 4) 
trans-6-Cyano-4-(N- 
methylsulphonyI-N-methylamino)-3- 
hydroxy-2,2-dimethyl-chromane 
ICso Ipmol/ll, chemical name 
360B 
Racemate 
369B 
~N.SO= 48.2 + 1.74, (n = 4) 
C ~ O  t rans-6-Cya no-3-hyd roxy-2,2- 
N . .  H dimethyl-4-(1,1-dioxo-2- 
isot hiazolidinyl)-chromane 
58.8 + 1.81, (n = 4) 
N/" SO trans-6-Cya no-4-[N-(1 - 
c ~ o  butylsulphonyl)-N-methylamino]-3- 
N . H hydroxy-2,2-dimet hyl-chromane 
[~[  48.2 + 3.46, (n = 4) 
~ , H  (+)-(3S,4R)-3-hydroxy-2,2- 
dimethyl-4-(2-oxo-l-pyrrolidinyl)-6- 
SO phenylsulphonyl-chromane 
368B ~ )  > 300, (n = 4) ~ 
:~0 (-)-(3R,4S)-3-hyd roxy-2,2- 
OH dimethyl-4-(2-oxo-l-pyffolidinyl)-6- 
SO phenylsulphonyl-chromane 
serosal perfusate. When a stable secretory L,, was obtained the puta- 
tive blockers were added to the serosal perfusate. 
3. Results 
As previously described, expression of LK and Kvl.1 chan- 
nels in Xenopus oocytes resulted in the induction of slowly and 
fast activating voltage-dependent K + currents, respectively 
[1,14], while Kir2.1 expression induced an inward-rectifier 
K + channel [15]. 293B (at 30 gmol/l; for chemical name see 
Table 1), the most potent cAMP-regulated K + channel inhib- 
itor in rabbit and rat colon crypts [9,11,12], had no inhibitory 
effects on Kvl.1 and Kir2.1 (Fig. 1; n=6 and 6 for Kvl.1 and 
Kir2.1, respectively). However, 293B (at 30 gmol/1) inhibited 
IsK channels almost completely (Fig. 1 ; 91.9 + 0.9°/,,; n -- 8). 
This effect was completely and rapidly reversible upon wash- 
out. 
A concentration-blockade relation for 293B on I,~K yielded 
an IC~0 of 6.9 gmol/1 (Fig. 2; ICs0 means+S.E.M, for all 
chromanols are listed in Table 1), a value which corresponds 
to its effects on cAMP-regulated K + channels in colon crypts 
[11]. As previously mentioned, IsK channels are positively 
regulated by activation of protein kinase A (PKA) [17]. Effects 
of 293B on I~n were therefore also tested after PKA-mediated 
regulation. Superfusion of oocytes expressing IsK with forsko- 
lin (10 gmol/1) and IBMX (1 mM) increased IsK by 
83.1 + 16.5% (n = 4), similar to that described by Blumenthal 
and Kaczmarek [17]. The inhibitory potency of 293B on regu- 
lated I~K was not significantly altered; following PKA- 
mediated increase of I~K the IC50 for 293B was 5.18+0.27 
gmol/1 (n = 4). 
293B is a racemate, and its stereoisomers (diastomers) 434B 
and 407B differed in their effects in colon crypts approxi- 
mately 10-fold. Similarly, 434B and 407B had distinct inhibi- 
#,-- 
+/- 293B 
Kv1.1 
m 
1 gA 
0 .1s  
control 
+/- 293B _ , 
IIII~ ~-  0.1 s 0.1 gA 
Kir2.1 IsK 
4s  
Fig. 1. Effects of 293B (30 gmol/1) on the K + channels Kvl.1, Kir2.1 and LK- The voltage clamp protocol for the K + channels i  described in 
Section 2. 
H. Suessbrich et al./FEBS Letters 396 (1996) 271-275 273 
,~  ~ontrol 
293B / /  3 
10 
0.2 gA 
4 ~  ~ontrol 
43 3 
~~~~. ._~M 10.2 gA 
6s 
control 
3 
10 
3O 
100 
6s 
/ /  
• 293B ,,, 
0 434B ~ 
[] 407B 
8O 
• 374B 7 / ~, 
o~ 60 • 439B / / ---- o 360B / _ /  
z~ 369B / P 
• ~"= • 368B/  / J 
4o 
/ /  
/ 
20 
0 . . . . . . . . . . . . . . . .  ; ' ' '  
1 10 100 
l.tmol/I 
Fig. 2. Effects of the chromanol 293B and its enantiomers 434B and 407B on IsK channels expressed in Xenopus oocytes. IsK was evoked with 
15 s depolarizing steps from --80 to --10 mV. The graph illustrates the concentration-inhibition relation for all chromanols tested. The data 
present means_+ S.E.M. The IC50 values are given in Table 1. 
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Fig. 3. Rat distal colon, Ussing chamber experiment. Upper trace: original record of transepithelial voltage (Vt,., continuous line). Voltage de- 
flections are caused by constant current injection to determine transepithelial resistance. The effect of forskolin is partially reversed by the addi- 
tion of azimilide in increasing concentrations. 293B shows an additional effect on Vu~ in the presence of azimilide. Lower panels: Effect of azi- 
milide (AZI) and additional effect of 293B on Vt, and equivalent short circuit current (I~) in the presence of forskolin (FSK). *Significantly 
different from Vt,~ and I~,, under FSK alone. 
tory potencies on Isn with respective ICs0 of 5 ~mol/l and 31 
p, mol/l (Fig. 2; Table 1). Moreover, 5 other chromanol deri- 
vatives were tested which had been shown to exert distinct 
inhibitory potencies on the cAMP-regulated K + conductance 
in colon crypts in the study of Lohrmann et al. [11]. These 
chromanols also exerted distinct inhibitory potencies on I~K 
expressed in Xenopus oocytes with ICs0 values of 20 500 
p, mol/l, in the same order of potency (for details see Table 1). 
I~K channels and the cardiac conductance IK~ have recently 
been shown to be inhibited by the novel class III antiarrhyth- 
mic azimilide [4]. In Ussing chamber experiments (n = 7) the 
effects of azimilide on transepithelial transport were exam- 
ined. Transepithelial voltage (Vte) and equivalent short circuit 
current (I~c) were taken as a measure of electrogenic CI- 
transport similar to what was previously described [11]. 
Stimulation of cAMP-dependent C1 secretion by forskolin 
(FSK, 10 ~tmol/1) increased Vt~ from -7.7_+0.7 mV to 
- 10.8 + 1.0 mV and I~ increased from 125 + 21 ~.A/cm 2 to 
-201 _+ 37 ~A/cm 2. In the presence of FSK azimilide inhibited 
Vte and I~ concentration-dependently by 3% (1 ~tmol/1), 15% 
(10 ~tmol/1) and 69% (100 ~mol/1). At a concentration of 100 
~mol Vto and I~o were reduced by 2.2 _+ 0.4 mV and by 52 _+ 16 
9A/cm 2 (Fig. 3), respectively, which was close to Vt~, and Is~ 
before FSK treatment. 293B (100 pmol/1) had an additional 
effects in the presence of azimilide (100 ~mol/1) and blocked 
the remaining FSK stimulated secretion completely. In all 
experiments Vt,~ and I~,~ were reduced by additional superfu- 
sion with 293B (100 ~[mol/1) to -6 .8+0.6  mV and 113_+17 
~A/cm 2 (Fig. 3), respectively. 
4. Discussion 
In colon crypt cells luminal cAMP-mediated C1- secretion 
requires the activation of a basolateral K + conductance to 
provide the necessary electrical driving force for CI . Ecke 
et al. [12] demonstrated recently in whole cell patch clamp 
experiments an inhibition of the basolateral K + conductance 
in rat colon crypts by novel chromanol derivatives, thereby 
completely inhibiting C1 secretion caused by several hor- 
mones. A number of observations of the present study indi- 
cate that I~K channels are the source of this epithelial K + 
conductance: (a) IsK inhibition mediated by chromanols oc- 
curred at similar concentrations and with a similar rank order 
of potency as observed for the colon cAMP-regulated K + 
conductance [11]; (b) the chromanols inhibited I~n channels 
potently without affecting other cloned K + channels; (c) espe- 
cially intriguing is the stereospecificity of the I~K inhibition by 
chromanols. The stereoisomers of the racemate compound 
293B inhibited IsK channels with different potencies, again in 
perfect correlation with their effects in colon crypts [11]; (d) 
finally, the I~K blocker azimilide also inhibits FSK mediated 
C1- secretion in colon crypts. However, azimilide is with an 
estimated ICs0 of 48 ~tM for I~c in rat colon about 10 times 
weaker than for I~n channels expressed in Xenopus oocytes [4]. 
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In summary, the present study demonstrates almost identi- 
cal pharmacological properties of InK channels expressed in 
Xenopus oocytes and the cAMP-activated K + conductance 
in colon crypts. Moreover, parallel studies could also demon- 
strate a 293B mediated inhibition of the I~K protein underlying 
cardiac conductance IK~ in guinea pig cardiocytes [18] and IsK 
channels in strial marginal cells in the inner ear [19]. The 
present study suggests therefore that I~K channels are the mol- 
ecular target for the chromanol 293B and its analogues. 
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